To enhance efficiency and consistency in the sampling procedures of drugs, cosmetics, and medical devices, while also ensuring the maintenance of a centralized monthly database of NSQ (Not of Standard Quality)/Spurious drugs, the CDSCO has drafted regulatory guidelines.   

These guidelines have been formulated to be adopted by drug inspectors of both Central and State Drug Authorities. The draft regulatory guidelines were circulated to all zonal/sub-zonal offices of CDSCO and State Licensing Authorities for their valuable input and suggestions.   

Subsequently, inputs and suggestions were received and have been duly incorporated into the guidance document. The final version of the guidance document, inclusive of all relevant inputs and suggestions, is now ready for implementation.   

This notification serves as an official directive for all Central and State Drug Authorities to adopt and implement the finalized regulatory guidelines for sampling of drugs, cosmetics, and medical devices.  

Access the official notification from here. 

Note: To keep up with the market and know about the latest regulations and notifications watch our Publication or subscribe to our WhatsApp channel.